Rheumatologic Disorder Clinical Trial
Official title:
Identifying Novel Biomarkers in Early Rheumatology Patients
Patients new to a rheumatology practice will be asked if they want to consent to their blood sample, medical records, and hand/foot x-rays (with sharp scores) for the analysis and correlation with the diagnosis they will receive from the rheumatologist.
At the end of their first visit new rheumatology patients will be asked for their interest in
joining the Inova biomarker study. If yes, the patient will be consented, blood will be drawn
for the Inova biomarkers, and x-rays will be sent for sharp scoring. Patients may decline and
will not be part of the Inova study. Patients who decline will continue to receive standard
of care treatment henceforth.
Patients in the Inova trial will receive a diagnosis from their doctor and are placed into
separate cohorts based upon their diagnosis. The Inova biomarker results of each cohort will
be cross-correlated with diagnoses, pre-screening tool results. Baseline disease activity and
sharp scores will also be correlation variables.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01685372 -
Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults
|
Phase 2 | |
Completed |
NCT03277703 -
Flu Vaccine Response in Patients on Biologic Therapies
|
Phase 2 | |
Withdrawn |
NCT03041571 -
Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
|
||
Active, not recruiting |
NCT04244968 -
Satisfaction, QoL,Health Status & Clinic Outcomes for Patients Attending MSK Triage Clinics in Rheumatology
|
||
Not yet recruiting |
NCT04702295 -
ERN ReCONNET Study on COVID-19 Vaccination in Rare and Complex Connective Tissue Disease (VACCINATE)
|
||
Completed |
NCT02678910 -
Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis/Treatment
|
N/A |